Can Bioplus bounce back from revenue stagnation after PE investor's exit?
Advertisement

Can Bioplus bounce back from revenue stagnation after PE investor's exit?

By Sreeja Biswas

  • 06 Jun 2024
Premium
Can Bioplus bounce back from revenue stagnation after PE investor's exit?
Sundeep Aurora, chairman and CEO, Bioplus Lifesciences | Credit: Linkedin

Healthcare supplements maker Bioplus Life Sciences Pvt. Ltd, which was a portfolio company for Asia-focused private equity firm AIF Capital until 2019, has been hovering on a revenue plateau for the last four fiscal years, primarily due to financial support provided to its loss-making subsidiary. The Bengaluru-headquartered firm, which markets most ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News